Dudediligence.

Jade Biosciences, Inc

JBIONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$16.3MSep ’24−$5.4MDec ’24−$38.2MMar ’25−$32.1MJun ’25−$25.2MSep ’25−$31.9MDec ’25−$40.4MMar ’26−$55.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$23.0M−$53.2M−$81.4M−$74.6M−$113.5M
Net income−$23.0M−$51.5M−$75.5M−$69.6M−$127.4M
Operating cash flow−$27.4M−$39.1M−$56.8M−$71.2M−$94.7M
Free cash flow−$27.6M−$39.3M−$56.9Mnone on file−$94.9M
Cash$54.2M$22.4M$23.5M$69.4M$88.4M
Shares outstanding24.4M24.7M27.8M3.7M49.3M